Ynvisible Reports Commercial Momentum and Expanding Market Engagements in 2025/2026
Cathedra Bitcoin Announces Third Quarter 2025 Financial Results
Thermosoft Australia Partners with European Design Leader Faro to Launch Premium Ceiling Fans Down Under
Cleantek Industries Inc. Reports Strong Third Quarter 2025 Results
Predictmedix AI Announces Closing of $460,150 First Tranche
WARREN, N.J., Feb. 28, 2022 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical…
SOUTH SAN FRANCISCO, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) — In a release issued under…
IRVINE, Calif.–(BUSINESS WIRE)–Allen Matkins, a California-based, full-service real estate and business law firm, announced today…
Deal deepens iCapital’s relationship with one of the fastest growing Asian private banks and accelerates…
CHICAGO, Feb. 28, 2022 (GLOBE NEWSWIRE) — Cosmos Holdings, Inc. (“the Company”) (Nasdaq: COSM), an…
CAMBRIDGE, Mass., Feb. 28, 2022 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology…
OTO-313 Phase 2 trial in tinnitus fully enrolled ahead of schedule with top-line results expected…
Cash and cash equivalents totaled €258.8 million as of December 31, 2021, which includes the…
— First Participants Dosed in Phase 1/2 Clinical Study Evaluating VAX-24 for the Prevention of…
RAS(ON) Inhibitor Pipeline Continues to Advance and Expand, Now Addressing Majority of RAS-Addicted Cancers; Two…
SOUTH SAN FRANCISCO, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX),…
Global biopharmaceutical industry senior executive with over 15 years of operational leadership with transactional and…
Provides 10-year market exclusivity in EU upon regulatory approval DEVON, Pa., Feb. 28, 2022 (GLOBE…
CAMBRIDGE, Mass., Feb. 28, 2022 (GLOBE NEWSWIRE) — Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a company…
SOUTH SAN FRANCISCO, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals (Nasdaq: DAWN),…
SOUTH SAN FRANCISCO, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) — Imago BioSciences, Inc. (“Imago”) (Nasdaq:…
Demonstrated tangible market progress and shipped 17 instruments through year end 2021 REDWOOD CITY, Calif.,…
Preliminary full year 2021 total revenues were $579.8 million; an 11% increase compared to $520.4…
EMERYVILLE, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) — Berkeley Lights, Inc. (Nasdaq: BLI), a leader…
Developing bemnifosbuvir (AT-527), a nucleotide analog, as preferred backbone of combination therapy for COVID-19, progressing…